New national survey on long-term health effects of COVID-19 launched

A major UK study on the long-term health effects of COVID-19 on inpatients has been initiated, involving researchers from the University of Liverpool.

The PHOSP-COVID study is awarded £8.4 million by the UK Research Innovation (UKRI) and the National Institutes of Health (NIHR). This study is one of the many COVID-19 studies that have been given an urgent public health research status by the Department of Health and Human Services.

The PHOSP-COVID study was led by the Leicester Biomedical Research Center at the National Institutes of Health (NIHR), utilizing the expertise of a consortium of leading researchers and clinicians throughout the UK to identify patients with COVID-19. Assess health and its impact on health. Their recovery. Researchers at the University of Liverpool are members of this consortium.

Approximately 10,000 patients are expected to participate, and understanding and improving the health of post-hospital survivors from COVID-19 has become the largest comprehensive study in the world.

Matt Hancock, Secretary of Health and Social Care, said:

“This world-leading research is another great contribution from the UK’s world-leading life sciences and research departments, and it also helps us to tailor future treatments to that person as closely as possible. I will.”

“We are very pleased to meet with our group,” said Chris Whitty, Chief Medical Officer. “It’s important to look at the long-term health effects of viruses, not just their direct health effects.

“We rightly focused on mortality and what Britain could do to save lives right away, but how COVID-19 might affect people’s health after recovery from the last illness. This should be considered. This UKRI and NIHR-funded study is one of the first steps to do this.”

Karm Semple“The professor of child health outbreak medicine at the University of Liverpool,” said: “Liverpool has both the skills and the expertise to study infectious diseases and is transforming the world. This study by survivors of covid-19 has added to our study explaining the Ebola syndrome. It is based.”

“Our involvement in this new study of COVID survivors will focus on respiratory problems and fatigue to better understand the long-term effects of this terrible disease. A better understanding of the causes of common health problems can help us develop rehabilitation programs and treatment strategies.”

The symptoms of COVID-19 depend on the person who responds positively. Some may not show symptoms, while others may develop severe pneumonia and sadly die. The need for medical, psychological, and rehabilitation to enable this patient group to recover as completely as possible is still unclear for those hospitalized and discharged.

Patients studied were evaluated using techniques such as advanced imaging, data collection, and analysis of blood and lung samples to provide a comprehensive view of the impact of COVID-19 on long-term health outcomes across the United Kingdom. Will be created.

The PHOSP-COVID team then went on to test new strategies for clinical care, including individualized treatment of patient groups based on the characteristics of the particular diseases they show as a result of improving the long-term health status of COVID-19. To develop.

“The UK’s chief research and innovation officer, Professor Otlin Racer, said: “There is a lot to learn about the long-term health effects of COVID-19 and its management in the hospital, including the effects of lung and heart weakness, fatigue, and trauma. Mental health and patient health. UKRI, in collaboration with NIHR, is funding one of the world’s largest studies to track the long-term effects of the virus after hospital treatment, which will help improve better care and rehabilitation. We hope to support and improve the lives of survivors.”

“The University of Leicester is vice president and president,” said Professor Nishan Canagarajah. “The University of Leicester continues to play a leading role beyond the UK in research on health. Trust in researchers as pioneering research and a citizen of true change through the recognition of PHOSP-COVID research. Incredibly proud of the work of researchers across the coronavirus pandemic, who have demonstrated the power and importance of research that transforms patient outcomes and ultimately the world to save lives. I am thinking.”

“Professor Melanie Davis, director of the NIHR Leicester Center for Biomedical Research, said: “The purpose of the Biomedical Research Center is to turn scientific progress into profits that are patient-paced.

“The coronavirus pandemic underscores the value of a center like ours in Leicester and leads the research embedded in the clinical care environment, which directly impacts patient care. We are pleased to have been awarded this prestigious funding to continue the exemplary record, in the fight against the Coronavirus.”

PHOSP-COVID research is based on NIHR infrastructure, including translational research collaborations on respiratory, mental health, cardiovascular, dementia, diet, exercise and nutrition, and many NIHR biomedical research centers set up for translation. Widely supported throughout. Laboratory-based scientific breakthroughs to potential new therapies, diagnostics and medical technologies.